Rohto Pharmaceutical Co (TSE:4527) Moat Score: 0/10 (As of Jul. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4527 Rohto Pharmaceutical Co Ltd TSE:4527
92 GF Score
Price 円2,435.00
GF Value 円3,477.35
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Rohto Pharmaceutical Co Moat Score?

Rohto Pharmaceutical Co has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Rohto Pharmaceutical Co has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Rohto Pharmaceutical Co might have No Moat - No discernible moat.

Rohto Pharmaceutical Co  (TSE:4527) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Rohto Pharmaceutical Co Moat Score Related Terms

TSE:4527
92GF Score
Rohto Pharmaceutical Co Ltd TSE:4527
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Rohto Pharmaceutical Co (TSE:4527) Overvalued in 2026?

Based on GuruFocus' analysis, Rohto Pharmaceutical Co stock appears to be undervalued. The current stock price of 円2,435.00 is trading 30% below its estimated GF Value™ of 円3,477.35. GuruFocus considers Rohto Pharmaceutical Co to be Significantly Undervalued.

Key valuation signals for TSE:4527:

  • Moat Score: 0
  • GF Value™: 円3,477.35 vs. price of 円2,435.00 (30% below fair value)
  • GF Score™: 92/100 with 2 warning signs

No single metric tells the full story. See the TSE:4527 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rohto Pharmaceutical Co Business Description

Other Exchanges RPHCF:USAUC1:Germany
Address 1-8-1 Tatsuminishi, Ikuno-ku, Osaka, JPN, 544-8666
Rohto Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of health and beauty care products. The company operates through four reportable segments: Japan, America, Europe, and Asia. Each segment manufactures and sells products related to eye care (such as eye drops and eyewash), skin care (including dermatological medications, lip balm, sunscreen, and functional cosmetics), oral medication (such as gastrointestinal and herbal medicines, and supplements), and other products such as in-vitro diagnostic reagents. It generates the majority of its revenue from Japan.
92GF Score

Get the complete analysis for TSE:4527

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,435.00
Price
円3,477.35
GF Value